Novel Therapeutic Targets for Tumor Microenvironment in Cancer

Roberto Bei¹, Laura Masuelli²

Affiliations

¹ Department of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.
² Department of Experimental Medicine, University of Rome "Sapienza", 00161 Rome, Italy.

PMID: 37108403
PMCID: PMC10138760
DOI: 10.3390/ijms24087240

Editorial

Novel Therapeutic Targets for Tumor Microenvironment in Cancer

Roberto Bei et al. Int J Mol Sci. 2023.

. 2023 Apr 14;24(8):7240.

doi: 10.3390/ijms24087240.

Authors

Roberto Bei¹, Laura Masuelli²

Affiliations

¹ Department of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.
² Department of Experimental Medicine, University of Rome "Sapienza", 00161 Rome, Italy.

PMID: 37108403
PMCID: PMC10138760
DOI: 10.3390/ijms24087240

Abstract

The various immune effector cells that infiltrate the tumor microenvironment (TME) play a key role in directing the outcome of tumor growth [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Cited by

A novel immune cell signature for predicting glioblastoma after radiotherapy prognosis and guiding therapy.
Huang R, Lu X, Sun X, Wu H. Huang R, et al. Int J Immunopathol Pharmacol. 2024 Jan-Dec;38:3946320241249395. doi: 10.1177/03946320241249395. Int J Immunopathol Pharmacol. 2024. PMID: 38687369 Free PMC article.
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition.
Glaviano A, Lau HS, Carter LM, Lee EHC, Lam HY, Okina E, Tan DJJ, Tan W, Ang HL, Carbone D, Yee MY, Shanmugam MK, Huang XZ, Sethi G, Tan TZ, Lim LHK, Huang RY, Ungefroren H, Giovannetti E, Tang DG, Bruno TC, Luo P, Andersen MH, Qian BZ, Ishihara J, Radisky DC, Elias S, Yadav S, Kim M, Robert C, Diana P, Schalper KA, Shi T, Merghoub T, Krebs S, Kusumbe AP, Davids MS, Brown JR, Kumar AP. Glaviano A, et al. J Hematol Oncol. 2025 Jan 13;18(1):6. doi: 10.1186/s13045-024-01634-6. J Hematol Oncol. 2025. PMID: 39806516 Free PMC article. Review.

References

1. Quail D.F., Joyce J.A. Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 2013;19:1423–1437. doi: 10.1038/nm.3394. - DOI - PMC - PubMed
1. Wen Y., Zhu Y., Zhang C., Yang X., Gao Y., Li M., Yang H., Liu T., Tang H. Chronic inflammation, cancer development and immunotherapy. Front. Pharmacol. 2022;13:1040163. doi: 10.3389/fphar.2022.1040163. - DOI - PMC - PubMed
1. Qin Y., Lu F., Lyu K., Chang A.E., Li Q. Emerging concepts regarding pro- and anti tumor properties of B cells in tumor immunity. Front. Immunol. 2022;13:881427. doi: 10.3389/fimmu.2022.881427. - DOI - PMC - PubMed
1. Masuelli L., Benvenuto M., Focaccetti C., Ciuffa S., Fazi S., Bei A., Miele M.T., Piredda L., Manzari V., Modesti A., et al. Targeting the tumor immune microenvironment with “nutraceuticals”: From bench to clinical trials. Pharmacol. Ther. 2021;219:107700. doi: 10.1016/j.pharmthera.2020.107700. - DOI - PubMed
1. Focaccetti C., Izzi V., Benvenuto M., Fazi S., Ciuffa S., Giganti M.G., Potenza V., Manzari V., Modesti A., Bei R. Polyphenols as Immunomodulatory Compounds in the Tumor Microenvironment: Friends or Foes? Int. J. Mol. Sci. 2019;20:1714. doi: 10.3390/ijms20071714. - DOI - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Novel Therapeutic Targets for Tumor Microenvironment in Cancer

Affiliations

Novel Therapeutic Targets for Tumor Microenvironment in Cancer

Authors

Affiliations

Abstract

Conflict of interest statement

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical